Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.

Identifieur interne : 001564 ( PubMed/Checkpoint ); précédent : 001563; suivant : 001565

The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.

Auteurs : Matthijs Raaben [Pays-Bas] ; Clara C. Posthuma ; Monique H. Verheije ; Eddie G. Te Lintelo ; Marjolein Kikkert ; Jan W. Drijfhout ; Eric J. Snijder ; Peter J M. Rottier ; Cornelis A M. De Haan

Source :

RBID : pubmed:20484504

Descripteurs français

English descriptors

Abstract

The ubiquitin-proteasome system (UPS) is a key player in regulating the intracellular sorting and degradation of proteins. In this study we investigated the role of the UPS in different steps of the coronavirus (CoV) infection cycle. Inhibition of the proteasome by different chemical compounds (i.e., MG132, epoxomicin, and Velcade) appeared to not only impair entry but also RNA synthesis and subsequent protein expression of different CoVs (i.e., mouse hepatitis virus [MHV], feline infectious peritonitis virus, and severe acute respiratory syndrome CoV). MHV assembly and release were, however, not appreciably affected by these compounds. The inhibitory effect on CoV protein expression did not appear to result from a general inhibition of translation due to induction of a cellular stress response by the inhibitors. Stress-induced phosphorylation of eukaryotic translation initiation factor 2alpha (eIF2alpha) generally results in impaired initiation of protein synthesis, but the sensitivity of MHV infection to proteasome inhibitors was unchanged in cells lacking a phosphorylatable eIF2alpha. MHV infection was affected not only by inhibition of the proteasome but also by interfering with protein ubiquitination. Viral protein expression was reduced in cells expressing a temperature-sensitive ubiquitin-activating enzyme E1 at the restrictive temperature, as well as in cells in which ubiquitin was depleted by using small interfering RNAs. Under these conditions, the susceptibility of the cells to virus infection was, however, not affected, excluding an important role of ubiquitination in virus entry. Our observations reveal an important role of the UPS in multiple steps of the CoV infection cycle and identify the UPS as a potential drug target to modulate the impact of CoV infection.

DOI: 10.1128/JVI.00485-10
PubMed: 20484504


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:20484504

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.</title>
<author>
<name sortKey="Raaben, Matthijs" sort="Raaben, Matthijs" uniqKey="Raaben M" first="Matthijs" last="Raaben">Matthijs Raaben</name>
<affiliation wicri:level="4">
<nlm:affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Utrecht</orgName>
</affiliation>
</author>
<author>
<name sortKey="Posthuma, Clara C" sort="Posthuma, Clara C" uniqKey="Posthuma C" first="Clara C" last="Posthuma">Clara C. Posthuma</name>
</author>
<author>
<name sortKey="Verheije, Monique H" sort="Verheije, Monique H" uniqKey="Verheije M" first="Monique H" last="Verheije">Monique H. Verheije</name>
</author>
<author>
<name sortKey="Te Lintelo, Eddie G" sort="Te Lintelo, Eddie G" uniqKey="Te Lintelo E" first="Eddie G" last="Te Lintelo">Eddie G. Te Lintelo</name>
</author>
<author>
<name sortKey="Kikkert, Marjolein" sort="Kikkert, Marjolein" uniqKey="Kikkert M" first="Marjolein" last="Kikkert">Marjolein Kikkert</name>
</author>
<author>
<name sortKey="Drijfhout, Jan W" sort="Drijfhout, Jan W" uniqKey="Drijfhout J" first="Jan W" last="Drijfhout">Jan W. Drijfhout</name>
</author>
<author>
<name sortKey="Snijder, Eric J" sort="Snijder, Eric J" uniqKey="Snijder E" first="Eric J" last="Snijder">Eric J. Snijder</name>
</author>
<author>
<name sortKey="Rottier, Peter J M" sort="Rottier, Peter J M" uniqKey="Rottier P" first="Peter J M" last="Rottier">Peter J M. Rottier</name>
</author>
<author>
<name sortKey="De Haan, Cornelis A M" sort="De Haan, Cornelis A M" uniqKey="De Haan C" first="Cornelis A M" last="De Haan">Cornelis A M. De Haan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20484504</idno>
<idno type="pmid">20484504</idno>
<idno type="doi">10.1128/JVI.00485-10</idno>
<idno type="wicri:Area/PubMed/Corpus">001696</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001696</idno>
<idno type="wicri:Area/PubMed/Curation">001696</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001696</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001564</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001564</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.</title>
<author>
<name sortKey="Raaben, Matthijs" sort="Raaben, Matthijs" uniqKey="Raaben M" first="Matthijs" last="Raaben">Matthijs Raaben</name>
<affiliation wicri:level="4">
<nlm:affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Utrecht</orgName>
</affiliation>
</author>
<author>
<name sortKey="Posthuma, Clara C" sort="Posthuma, Clara C" uniqKey="Posthuma C" first="Clara C" last="Posthuma">Clara C. Posthuma</name>
</author>
<author>
<name sortKey="Verheije, Monique H" sort="Verheije, Monique H" uniqKey="Verheije M" first="Monique H" last="Verheije">Monique H. Verheije</name>
</author>
<author>
<name sortKey="Te Lintelo, Eddie G" sort="Te Lintelo, Eddie G" uniqKey="Te Lintelo E" first="Eddie G" last="Te Lintelo">Eddie G. Te Lintelo</name>
</author>
<author>
<name sortKey="Kikkert, Marjolein" sort="Kikkert, Marjolein" uniqKey="Kikkert M" first="Marjolein" last="Kikkert">Marjolein Kikkert</name>
</author>
<author>
<name sortKey="Drijfhout, Jan W" sort="Drijfhout, Jan W" uniqKey="Drijfhout J" first="Jan W" last="Drijfhout">Jan W. Drijfhout</name>
</author>
<author>
<name sortKey="Snijder, Eric J" sort="Snijder, Eric J" uniqKey="Snijder E" first="Eric J" last="Snijder">Eric J. Snijder</name>
</author>
<author>
<name sortKey="Rottier, Peter J M" sort="Rottier, Peter J M" uniqKey="Rottier P" first="Peter J M" last="Rottier">Peter J M. Rottier</name>
</author>
<author>
<name sortKey="De Haan, Cornelis A M" sort="De Haan, Cornelis A M" uniqKey="De Haan C" first="Cornelis A M" last="De Haan">Cornelis A M. De Haan</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Boronic Acids (pharmacology)</term>
<term>Bortezomib</term>
<term>Cats</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Coronavirus Infections (virology)</term>
<term>Coronavirus, Feline (pathogenicity)</term>
<term>Leupeptins (pharmacology)</term>
<term>Mice</term>
<term>Murine hepatitis virus (pathogenicity)</term>
<term>Oligopeptides (pharmacology)</term>
<term>Protease Inhibitors (pharmacology)</term>
<term>Proteasome Endopeptidase Complex (metabolism)</term>
<term>Proteasome Inhibitors</term>
<term>Pyrazines (pharmacology)</term>
<term>SARS Virus (pathogenicity)</term>
<term>Ubiquitin (metabolism)</term>
<term>Virus Internalization</term>
<term>Virus Release</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acides boroniques (pharmacologie)</term>
<term>Animaux</term>
<term>Bortézomib</term>
<term>Chats</term>
<term>Coronavirus félin (pathogénicité)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Inhibiteurs de protéases (pharmacologie)</term>
<term>Inhibiteurs du protéasome</term>
<term>Leupeptines (pharmacologie)</term>
<term>Libération de particules virales</term>
<term>Lignée cellulaire</term>
<term>Oligopeptides (pharmacologie)</term>
<term>Proteasome endopeptidase complex (métabolisme)</term>
<term>Pyrazines (pharmacologie)</term>
<term>Pénétration virale</term>
<term>Réplication virale</term>
<term>Souris</term>
<term>Ubiquitine (métabolisme)</term>
<term>Virus de l'hépatite murine (pathogénicité)</term>
<term>Virus du SRAS (pathogénicité)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Proteasome Endopeptidase Complex</term>
<term>Ubiquitin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Boronic Acids</term>
<term>Leupeptins</term>
<term>Oligopeptides</term>
<term>Protease Inhibitors</term>
<term>Pyrazines</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Proteasome endopeptidase complex</term>
<term>Ubiquitine</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Coronavirus, Feline</term>
<term>Murine hepatitis virus</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Coronavirus félin</term>
<term>Virus de l'hépatite murine</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Acides boroniques</term>
<term>Inhibiteurs de protéases</term>
<term>Leupeptines</term>
<term>Oligopeptides</term>
<term>Pyrazines</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Bortezomib</term>
<term>Cats</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Mice</term>
<term>Proteasome Inhibitors</term>
<term>Virus Internalization</term>
<term>Virus Release</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Bortézomib</term>
<term>Chats</term>
<term>Inhibiteurs du protéasome</term>
<term>Libération de particules virales</term>
<term>Lignée cellulaire</term>
<term>Pénétration virale</term>
<term>Réplication virale</term>
<term>Souris</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The ubiquitin-proteasome system (UPS) is a key player in regulating the intracellular sorting and degradation of proteins. In this study we investigated the role of the UPS in different steps of the coronavirus (CoV) infection cycle. Inhibition of the proteasome by different chemical compounds (i.e., MG132, epoxomicin, and Velcade) appeared to not only impair entry but also RNA synthesis and subsequent protein expression of different CoVs (i.e., mouse hepatitis virus [MHV], feline infectious peritonitis virus, and severe acute respiratory syndrome CoV). MHV assembly and release were, however, not appreciably affected by these compounds. The inhibitory effect on CoV protein expression did not appear to result from a general inhibition of translation due to induction of a cellular stress response by the inhibitors. Stress-induced phosphorylation of eukaryotic translation initiation factor 2alpha (eIF2alpha) generally results in impaired initiation of protein synthesis, but the sensitivity of MHV infection to proteasome inhibitors was unchanged in cells lacking a phosphorylatable eIF2alpha. MHV infection was affected not only by inhibition of the proteasome but also by interfering with protein ubiquitination. Viral protein expression was reduced in cells expressing a temperature-sensitive ubiquitin-activating enzyme E1 at the restrictive temperature, as well as in cells in which ubiquitin was depleted by using small interfering RNAs. Under these conditions, the susceptibility of the cells to virus infection was, however, not affected, excluding an important role of ubiquitination in virus entry. Our observations reveal an important role of the UPS in multiple steps of the CoV infection cycle and identify the UPS as a potential drug target to modulate the impact of CoV infection.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">20484504</PMID>
<DateCompleted>
<Year>2010</Year>
<Month>07</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>84</Volume>
<Issue>15</Issue>
<PubDate>
<Year>2010</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.</ArticleTitle>
<Pagination>
<MedlinePgn>7869-79</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00485-10</ELocationID>
<Abstract>
<AbstractText>The ubiquitin-proteasome system (UPS) is a key player in regulating the intracellular sorting and degradation of proteins. In this study we investigated the role of the UPS in different steps of the coronavirus (CoV) infection cycle. Inhibition of the proteasome by different chemical compounds (i.e., MG132, epoxomicin, and Velcade) appeared to not only impair entry but also RNA synthesis and subsequent protein expression of different CoVs (i.e., mouse hepatitis virus [MHV], feline infectious peritonitis virus, and severe acute respiratory syndrome CoV). MHV assembly and release were, however, not appreciably affected by these compounds. The inhibitory effect on CoV protein expression did not appear to result from a general inhibition of translation due to induction of a cellular stress response by the inhibitors. Stress-induced phosphorylation of eukaryotic translation initiation factor 2alpha (eIF2alpha) generally results in impaired initiation of protein synthesis, but the sensitivity of MHV infection to proteasome inhibitors was unchanged in cells lacking a phosphorylatable eIF2alpha. MHV infection was affected not only by inhibition of the proteasome but also by interfering with protein ubiquitination. Viral protein expression was reduced in cells expressing a temperature-sensitive ubiquitin-activating enzyme E1 at the restrictive temperature, as well as in cells in which ubiquitin was depleted by using small interfering RNAs. Under these conditions, the susceptibility of the cells to virus infection was, however, not affected, excluding an important role of ubiquitination in virus entry. Our observations reveal an important role of the UPS in multiple steps of the CoV infection cycle and identify the UPS as a potential drug target to modulate the impact of CoV infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Raaben</LastName>
<ForeName>Matthijs</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Posthuma</LastName>
<ForeName>Clara C</ForeName>
<Initials>CC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Verheije</LastName>
<ForeName>Monique H</ForeName>
<Initials>MH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>te Lintelo</LastName>
<ForeName>Eddie G</ForeName>
<Initials>EG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kikkert</LastName>
<ForeName>Marjolein</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Drijfhout</LastName>
<ForeName>Jan W</ForeName>
<Initials>JW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Snijder</LastName>
<ForeName>Eric J</ForeName>
<Initials>EJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rottier</LastName>
<ForeName>Peter J M</ForeName>
<Initials>PJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>de Haan</LastName>
<ForeName>Cornelis A M</ForeName>
<Initials>CA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>05</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001897">Boronic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007976">Leupeptins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061988">Proteasome Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011719">Pyrazines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>69G8BD63PP</RegistryNumber>
<NameOfSubstance UI="D000069286">Bortezomib</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.25.1</RegistryNumber>
<NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>RF1P63GW3K</RegistryNumber>
<NameOfSubstance UI="C072553">benzyloxycarbonylleucyl-leucyl-leucine aldehyde</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>Y0900I3U8U</RegistryNumber>
<NameOfSubstance UI="C078846">epoxomicin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001897" MajorTopicYN="N">Boronic Acids</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000069286" MajorTopicYN="N">Bortezomib</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002415" MajorTopicYN="N">Cats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016765" MajorTopicYN="N">Coronavirus, Feline</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007976" MajorTopicYN="N">Leupeptins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006517" MajorTopicYN="N">Murine hepatitis virus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D061988" MajorTopicYN="N">Proteasome Inhibitors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011719" MajorTopicYN="N">Pyrazines</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D057074" MajorTopicYN="N">Virus Release</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>7</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20484504</ArticleId>
<ArticleId IdType="pii">JVI.00485-10</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.00485-10</ArticleId>
<ArticleId IdType="pmc">PMC2897594</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2007 Jun;81(11):6007-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17392370</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO Rep. 2007 Jun;8(6):550-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17545995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Cells. 2007 Jun;12(6):735-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17573774</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Jul;81(14):7380-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17507493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Microbiol. 2007 Sep;9(9):2218-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17490409</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Sep;81(18):10029-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17626072</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Dec;81(24):13631-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17913808</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Apr;82(7):3381-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18234803</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008;3(4):e1887</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18382670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Investig Drugs. 2008 Jun;17(6):879-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18491989</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2008 Jun;4(6):e1000088</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18551169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008;3(7):e2585</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18612413</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H401-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18515649</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Biol. 2008 Sep 16;6(9):e226</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18798692</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Mar;83(5):2099-108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19109393</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Mar;83(6):2469-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19129442</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Feb;84(4):2134-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20007278</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Aug;84(15):7880-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20484516</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Feb;74(3):1393-406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10627550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2000 Apr;81(Pt 4):853-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10725411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2000 May 19;275(20):15157-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10748218</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Jun;74(12):5647-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10823872</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1999;68:1015-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10872471</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Sep;74(17):7911-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10933699</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13063-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11087860</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2001 Jun;7(6):1165-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11430820</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chem Biol. 2001 Aug;8(8):739-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11514224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2001 Nov;75(22):10623-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11602704</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Apr;76(8):3697-708</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11907209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Dec;76(24):12634-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12438589</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12746549</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Aug;77(16):8801-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12885899</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Cell Biol. 2003 Aug;15(4):446-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12892785</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Nov;77(21):11312-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14557617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Cell Dev Biol. 2003;19:141-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14570567</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Traffic. 2003 Dec;4(12):857-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14617349</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Apr;10(4):368-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15034574</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jul;78(13):7175-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15194794</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Cancer. 2004 Oct;40(15):2217-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15454246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1988 Oct 25;263(30):15726-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3049611</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1990 Jun;64(6):3051-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1692350</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 1991 Jun 11;19(11):2993-3000</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2057357</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1992 Oct 25;267(30):21911-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1400501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lab Anim Sci. 1993 Feb;43(1):15-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8384676</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 1994 Jan;124(1-2):55-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8294506</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 1997 May 29;234(3):729-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9175783</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 1997 Nov 25;36(47):14418-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9398160</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1998;67:425-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9759494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Rep. 1999 Apr;26(1-2):3-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10363639</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10403-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10468620</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Biochem. 1999 Oct;265(2):754-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10504407</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Jan;79(1):644-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15596861</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Jan;79(2):884-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15613317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Apr;79(7):4550-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15767458</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2005 Apr 29;280(17):16925-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15684421</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Expr Purif. 2005 May;41(1):207-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15915565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Immunol. 2005;49(9):835-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16172538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Chem. 2005 Nov 3;48(22):6832-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16250642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Nov;79(22):14451-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16254381</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Dec;79(24):15189-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16306590</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Dec;79(24):15511-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16306622</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2006 Jan 5;344(1):55-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16364736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Med. 2006;57:33-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16409135</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Mar;80(5):2326-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16474139</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5717-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16581910</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2006 Apr 19;25(8):1730-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16601681</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2006 Jun;87(Pt 6):1403-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16690906</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2005 Dec;1(4):e39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16341254</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2006 Oct 10;354(1):1-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16920176</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Cell Dev Biol. 2006;22:159-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16753028</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Soc Trans. 2007 Feb;35(Pt 1):12-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17212580</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2007;13(5):471-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17348844</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
</country>
<region>
<li>Utrecht (province)</li>
</region>
<settlement>
<li>Utrecht</li>
</settlement>
<orgName>
<li>Université d'Utrecht</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="De Haan, Cornelis A M" sort="De Haan, Cornelis A M" uniqKey="De Haan C" first="Cornelis A M" last="De Haan">Cornelis A M. De Haan</name>
<name sortKey="Drijfhout, Jan W" sort="Drijfhout, Jan W" uniqKey="Drijfhout J" first="Jan W" last="Drijfhout">Jan W. Drijfhout</name>
<name sortKey="Kikkert, Marjolein" sort="Kikkert, Marjolein" uniqKey="Kikkert M" first="Marjolein" last="Kikkert">Marjolein Kikkert</name>
<name sortKey="Posthuma, Clara C" sort="Posthuma, Clara C" uniqKey="Posthuma C" first="Clara C" last="Posthuma">Clara C. Posthuma</name>
<name sortKey="Rottier, Peter J M" sort="Rottier, Peter J M" uniqKey="Rottier P" first="Peter J M" last="Rottier">Peter J M. Rottier</name>
<name sortKey="Snijder, Eric J" sort="Snijder, Eric J" uniqKey="Snijder E" first="Eric J" last="Snijder">Eric J. Snijder</name>
<name sortKey="Te Lintelo, Eddie G" sort="Te Lintelo, Eddie G" uniqKey="Te Lintelo E" first="Eddie G" last="Te Lintelo">Eddie G. Te Lintelo</name>
<name sortKey="Verheije, Monique H" sort="Verheije, Monique H" uniqKey="Verheije M" first="Monique H" last="Verheije">Monique H. Verheije</name>
</noCountry>
<country name="Pays-Bas">
<region name="Utrecht (province)">
<name sortKey="Raaben, Matthijs" sort="Raaben, Matthijs" uniqKey="Raaben M" first="Matthijs" last="Raaben">Matthijs Raaben</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001564 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001564 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:20484504
   |texte=   The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:20484504" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021